Stand out for this role — generate a tailored resume and cover letter in about a minute.
Regeneron Pharmaceuticals, Inc. in Tarrytown, NY seeks an independent bench Scientist to join the Ophthalmology group, developing in vitro assays and mouse models to study ocular autoimmunity and evaluate therapeutic candidates.
You will perform ELISA, MSD, Luminex, RT-PCR, and flow cytometry on mouse and human samples, isolate tissues, and contribute to data analysis and study reports; onsite work with cross-functional collaboration is expected.
Build our future together: At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking an independent and highly motivated bench Scientist to join our Ophthalmology group, supporting the development of therapeutics for ocular and autoimmune diseases. In this role, you will engage in innovative research as part of our discovery efforts, developing new in vitro assays and models to elucidate pathways involved in ocular autoimmunity and evaluating therapeutic candidates, while collaborating closely with teams across the organization. This position offers the opportunity to contribute to a fast-growing, science-driven organization making a meaningful difference to patients worldwide.
Location: Tarrytown, NY Work model/flexibility: Onsite
Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law.
Many roles are required to be performed on-site.
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurology, infectious diseases and rare diseases.
Regeneron is also proud of award-winning culture of innovation, being recognized as a Great Place to Work in 2021, Fast Company’s Best Workplace for Innovators in 2020, and Forbes JUST companies in 2020, among others.